Your browser doesn't support javascript.
loading
[Treatment of ALK negative metastatic inflammatory myofibroblastic tumor by combination of pembrolizumab and anlotinib: a case report].
Li, X S; Li, X F; Jin, L F; Zhao, Y; Shen, W Z.
Afiliação
  • Li XS; Department of Oncology and Hematology, the Second Hospital of Jilin University, Changchun 130041, China.
  • Li XF; Department of Oncology and Hematology, the Second Hospital of Jilin University, Changchun 130041, China.
  • Jin LF; Department of Oncology and Hematology, the Second Hospital of Jilin University, Changchun 130041, China.
  • Zhao Y; Department of Oncology and Hematology, the Second Hospital of Jilin University, Changchun 130041, China.
  • Shen WZ; Department of Oncology and Hematology, the Second Hospital of Jilin University, Changchun 130041, China.
Zhonghua Zhong Liu Za Zhi ; 43(2): 240-242, 2021 02 23.
Article em Zh | MEDLINE | ID: mdl-33601493
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias Limite: Humans Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias Limite: Humans Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article